Related Experiment Video

Updated: Jul 15, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.0K

Characterization of the generic mutant p53-rescue compounds in a broad range of assays

Shujun Xiao1, Fangfang Shi2, Huaxin Song2

  • 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.

Cancer Cell
|February 25, 2024
PubMed

Insights

Researchers evaluated mutant p53-rescue compounds, finding only arsenic trioxide (ATO) and its analog PAT effective. Most compounds failed to show reliable rescue in extensive assays, highlighting challenges in targeting mutant p53.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Mutant p53 proteins are frequently found in tumors and contribute to cancer development.
  • Numerous compounds have been developed with the aim of rescuing mutant p53 function.
  • Evaluating the efficacy of these compounds is crucial for therapeutic advancement.

Discussion:

  • Xiao et al. conducted a comprehensive side-by-side evaluation of 10 different mutant p53-rescue compounds.
  • The study employed 10 distinct assays to rigorously assess compound effectiveness.
  • This systematic approach aimed to identify reliable therapeutic candidates.

Key Insights:

  • Most evaluated compounds did not demonstrate significant or reliable rescue of tumor-associated mutant p53.
  • Arsenic trioxide (ATO) and its analog PAT were the only compounds showing a rescue effect in the assays.
  • This finding suggests limited efficacy of many reported p53-rescue strategies.

Outlook:

  • Further research is needed to understand the mechanisms behind ATO and PAT's activity.
  • Developing more effective and specific mutant p53-targeting therapies remains a critical goal.
  • This study provides valuable data for future drug development in p53-mutated cancers.

More Related Videos

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy06:38

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Published on: February 7, 2019

8.7K
Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.6K

Related Concept Videos

In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...